DNA adducts of aristolochic acid II: total synthesis and site-specific mutagenesis studies in mammalian cells

Aristolochic acids I and II (AA-I, AA-II) are found in all Aristolochia species. Ingestion of these acids either in the form of herbal remedies or as contaminated wheat flour causes a dose-dependent chronic kidney failure characterized by renal tubulointerstitial fibrosis. In ∼50% of these cases, the condition is accompanied by an upper urinary tract malignancy. The disease is now termed aristolochic acid nephropathy (AAN). AA-I is largely responsible for the nephrotoxicity while both AA-I and AA-II are genotoxic. DNA adducts derived from AA-I and AA-II have been isolated from renal tissues of patients suffering from AAN. We describe the total synthesis, de novo, of the dA and dG adducts derived from AA-II, their incorporation site-specifically into DNA oligomers and the splicing of these modified oligomers into a plasmid construct followed by transfection into mouse embryonic fibroblasts. Analysis of the plasmid progeny revealed that both adducts blocked replication but were still partly processed by DNA polymerase(s). Although the majority of coding events involved insertion of correct nucleotides, substantial misincorporation of bases also was noted. The dA adduct is significantly more mutagenic than the dG adduct; both adducts give rise, almost exclusively, to misincorporation of dA, which leads to AL-II-dA→T and AL-II-dG→T transversions.

[1]  M. Hollstein,et al.  TP53 mutation signature supports involvement of aristolochic acid in the aetiology of endemic nephropathy‐associated tumours , 2009, International journal of cancer.

[2]  N. de Wind,et al.  Two Distinct Translesion Synthesis Pathways across a Lipid Peroxidation-derived DNA Adduct in Mammalian Cells* , 2009, Journal of Biological Chemistry.

[3]  J. Scarborough,et al.  Chapter 7 Aristolochic Acid Nephropathy: An Environmental and Iatrogenic Disease , 2009 .

[4]  F. Debellé,et al.  Aristolochic acid nephropathy: a worldwide problem. , 2008, Kidney international.

[5]  V. Arlt,et al.  Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy. , 2008, Mutation research.

[6]  B. Jelaković,et al.  Role of environmental toxins in endemic (Balkan) nephropathy. October 2006, Zagreb, Croatia. , 2007, Journal of the American Society of Nephrology : JASN.

[7]  B. Jelaković,et al.  Aristolochic acid and the etiology of endemic (Balkan) nephropathy , 2007, Proceedings of the National Academy of Sciences.

[8]  A. Grollman,et al.  Selective Toxicity of Aristolochic Acids I and II , 2007, Drug Metabolism and Disposition.

[9]  H. Schut,et al.  Novel LC-ESI/MS/MS(n) method for the characterization and quantification of 2'-deoxyguanosine adducts of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by 2-D linear quadrupole ion trap mass spectrometry. , 2007, Chemical research in toxicology.

[10]  S. Hecht,et al.  Genotoxicity of acetaldehyde- and crotonaldehyde-induced 1,N2-propanodeoxyguanosine DNA adducts in human cells. , 2006, Mutation research.

[11]  N. Mei,et al.  Mutations induced by carcinogenic doses of aristolochic acid in kidney of Big Blue transgenic rats. , 2006, Toxicology letters.

[12]  Cyril Bressy,et al.  Synthesis of Polycyclic Lactams and Sultams by a Cascade Ring-Closure Metathesis/Isomerization and Subsequent Radical Cyclization. , 2005 .

[13]  B. Jelaković,et al.  Endemic nephropathy: the case for chronic poisoning by aristolochia. , 2005, Croatian medical journal.

[14]  Shih-Ming Chen,et al.  Acute nephrotoxicity of aristolochic acids in mice , 2004, The Journal of pharmacy and pharmacology.

[15]  U. Mengs,et al.  Tumour induction in mice following exposure to aristolochic acid , 2004, Archives of Toxicology.

[16]  J. Cosyns Aristolochic Acid and ‘Chinese Herbs Nephropathy’ , 2003, Drug safety.

[17]  P. Renard,et al.  Synthesis and biological evaluation of aristolactams. , 2002, Bioorganic & medicinal chemistry letters.

[18]  V. Arlt,et al.  Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. , 2002, Mutagenesis.

[19]  A. Kohara,et al.  Mutagenicity of aristolochic acid in the lambda/lacZ transgenic mouse (MutaMouse). , 2002, Mutation research.

[20]  A. Grollman,et al.  Genotoxic mechanism for the major acrolein-derived deoxyguanosine adduct in human cells. , 2002, Chemical research in toxicology.

[21]  M. Jadoul,et al.  Aristolochic acid nephropathy in a Chinese patient: time to abandon the term "Chinese herbs nephropathy"? , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  Y. Guiot,et al.  Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? , 2001, Kidney international.

[23]  J. Li,et al.  [Chinese herbs nephropathy]. , 2000, Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials.

[24]  F. Johnson,et al.  A General Method for the Synthesis of the N2- and N6- Carcinogenic Amine Adducts of 2‘-Deoxyguanosine and 2‘-Deoxyadenosine1 , 1999 .

[25]  J. Squifflet,et al.  Urothelial lesions in Chinese-herb nephropathy. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  E. Frei,et al.  Comparison of DNA adduct formation by aristolochic acids in various in vitro activation systems by 32P-post-labelling: evidence for reductive activation by peroxidases. , 1997, Carcinogenesis.

[27]  C. van Ypersele de Strihou,et al.  Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. , 1996, Cancer research.

[28]  L. Castedo,et al.  The intramolecular aryne cycloaddition approach to aporphinoids. A new total synthesis of aristolactams and phenanthrene alkaloids , 1995 .

[29]  L. Castedo,et al.  Tributyltin(IV) hydride mediated free-radical syntheses of dehydrodibenzochromanones, dehydrodibenzocoumaranones and aristolactams , 1995 .

[30]  C. W. von der Lieth,et al.  Translesional synthesis on DNA templates containing site-specifically placed deoxyadenosine and deoxyguanosine adducts formed by the plant carcinogen aristolochic acid. , 1994, Carcinogenesis.

[31]  C van Ypersele de Strihou,et al.  Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? , 1994, Kidney international.

[32]  P. But,et al.  Identification of aristolochic acid in Chinese herbs , 1994, The Lancet.

[33]  M. Jadoul,et al.  Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs , 1993, The Lancet.

[34]  M. Wiessler,et al.  N6-adenyl arylation of DNA by aristolochic acid II and a synthetic model for the putative proximate carcinogen. , 1991, Chemical research in toxicology.

[35]  M. Wiessler,et al.  32P-postlabelling analysis of the DNA adducts formed by aristolochic acid I and II. , 1990, Carcinogenesis.

[36]  L. Gundersen,et al.  (tert.‐Butyldimethylsilyloxy)methyl Chloride: Synthesis and Use as N‐Protecting Group in Pyrimidinones. , 1988 .

[37]  K. Bowden,et al.  Transmission of Polar Effects. Part 16. Ionization of 8-Substituted 1-Naphthoic Acids and the Alkaline Hydrolysis of Their Methyl Esters , 1987 .

[38]  K. Bowden,et al.  Transmission of polar effects. Part 16. Ionisation of 8-substituted 1-naphthoic acids and the alkaline hydrolysis of their methyl esters , 1986 .

[39]  H. Priestap Seven aristololactams from Aristolochia argentina , 1985 .

[40]  R. Borchardt,et al.  General method for the synthesis of phthalaldehydic acids and phthalides from o-bromobenzaldehydes via ortho-lithiated aminoalkoxides , 1983 .

[41]  M. Grieve A Modern Herbal: The Medicinal, Culinary, Cosmetic, and Economic Properties, Cultivation, and Folklore of Herbs, Grasses, Fungi, Shrubs, and Trees with All Their Modern Scientific Uses , 1980 .

[42]  F. Johnson Allylic strain in six-membered rings , 1968 .

[43]  B. Hirt Selective extraction of polyoma DNA from infected mouse cell cultures. , 1967, Journal of molecular biology.

[44]  M. Pailer,et al.  Die Konstitution der Aristolochiasäure-IV , 1967 .

[45]  S. M. Kupchan,et al.  Tumor inhibitors. X. Photochemical synthesis of phenanthrenes. Synthesis of aristolochic acid and related compounds. , 1965, The Journal of organic chemistry.

[46]  H. Brodovsky,et al.  ARISTOLOCHIC ACID (NSC-50413): PHASE I CLINICAL STUDY. , 1964, Cancer chemotherapy reports.

[47]  S. A. Glickman,et al.  Lactam Complexes of Bromine-Hydrogen Bromide , 1963 .

[48]  S. M. Kupchan,et al.  TUMOR INHIBITORS. I. ARISTOLOCHIC ACID, THE ACTIVE PRINCIPLE OF ARISTOLOCHIA INDICA. , 1962, Journal of medicinal and pharmaceutical chemistry.

[49]  P. Tomasic [Problem of the etiology of endemic nephropathy]. , 1960, Lijecnicki vjesnik.

[50]  M. Pailer,et al.  Pflanzliche Naturstoffe mit einer Nitrogruppe II Die Konstitution der Aristolochiasäure-II , 1956 .

[51]  H. G. Rule,et al.  23. Reactivity of peri-substituted naphthalenes. Part I. Displacement of the nitro-group in 8-nitro-1-naphthoic acid by thionyl halides to form 8-chloro- and 8-bromo-naphthoic acids , 1932 .

[52]  Hans Theodor Bucherer Über die Einwirkung schwefligsaurer Salze auf aromatische Amido- und Hydroxylverbindungen , 1904 .

[53]  EINZ,et al.  UROTHELIAL CARCINOMA ASSOCIATED WITH THE USE OF A CHINESE HERB ( ARISTOLOCHIA FANGCHI ) , 2022 .